These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6673210)

  • 1. Structural and functional alterations in H-2 antigen expression on tumor cells.
    Martin WJ
    Transplant Proc; 1983 Dec; 15(4):2097-100. PubMed ID: 6673210
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetic control of metastatic competence of cloned tumor cell populations.
    Eisenbach L; De Baetselier P; Katzav S; Segal S; Feldman M
    Symp Fundam Cancer Res; 1983; 36():101-21. PubMed ID: 6332357
    [No Abstract]   [Full Text] [Related]  

  • 4. Both H-2- and non-H-2-linked genes influence influenza nucleoprotein epitope recognition by CD4+ T cells.
    Brett SJ; Tite JP
    Immunology; 1996 Jan; 87(1):42-8. PubMed ID: 8666434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
    Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model.
    Grunhaus A; Cho S; Horwitz MS
    Virology; 1994 May; 200(2):535-46. PubMed ID: 8178441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
    Isakov N; Feldman M; Segal S
    J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens.
    Imamura M; Martin WJ
    J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody-induced modulation of H-2Kb antigens on mouse tumor cells in vitro.
    Stagsted J; Olsson L
    Cancer Detect Prev Suppl; 1987; 1():65-71. PubMed ID: 3480071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of regulatory genes in H-2D-end immune functions.
    Singh SK; David CS
    Transplant Proc; 1983 Dec; 15(4):2054-7. PubMed ID: 6673208
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour susceptibility in mice in relation to H-2 haplotype.
    Oomen LC; Van der Valk MA; Den Engelse L
    IARC Sci Publ; 1983; (51):205-21. PubMed ID: 6365770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
    Li M; Muller J; Xu F; Hearing VJ; Gorelik E
    Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between leukemia virus genomes and histocompatibility genes.
    Meruelo D
    Year Immunol; 1985; ():163-70. PubMed ID: 3033941
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccinia virus as a tool for immunologic studies.
    Tatsis N; Sinnathamby G; Eisenlohr LC
    Methods Mol Biol; 2004; 269():267-88. PubMed ID: 15114021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.
    Ozato K; Sachs DH
    J Immunol; 1981 Jan; 126(1):317-21. PubMed ID: 6935293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic characterization of products of cloned H-2b genes.
    Oudshoorn-Snoek M; Demant P; Mellor AL; Flavell RA
    Transplant Proc; 1983 Dec; 15(4):2027-32. PubMed ID: 6200973
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
    Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of minimally divergent allelic forms of the natural killer (NK) receptor Ly-49C, differentially controlled by host genes in the MHC and NK gene complexes.
    Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1996 Nov; 157(9):3936-42. PubMed ID: 8892625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
    Chen CH; Wang TL; Ji H; Hung CF; Pardoll DM; Cheng WF; Ling M; Wu TC
    Gene Ther; 2001 Jan; 8(2):128-38. PubMed ID: 11313782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.